Systematic Financial Management LP Buys Shares of 1,182,414 DENTSPLY SIRONA Inc. $XRAY

Systematic Financial Management LP purchased a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the first quarter, Holdings Channel reports. The fund purchased 1,182,414 shares of the medical instruments supplier’s stock, valued at approximately $13,716,000.

Several other large investors also recently made changes to their positions in the stock. Daiwa Securities Group Inc. increased its holdings in shares of DENTSPLY SIRONA by 2.9% during the 4th quarter. Daiwa Securities Group Inc. now owns 26,814 shares of the medical instruments supplier’s stock valued at $306,000 after acquiring an additional 767 shares during the last quarter. Blue Trust Inc. raised its stake in shares of DENTSPLY SIRONA by 10.8% in the 1st quarter. Blue Trust Inc. now owns 12,555 shares of the medical instruments supplier’s stock valued at $146,000 after acquiring an additional 1,226 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its holdings in DENTSPLY SIRONA by 3.3% in the 1st quarter. Oregon Public Employees Retirement Fund now owns 40,944 shares of the medical instruments supplier’s stock worth $475,000 after purchasing an additional 1,300 shares during the last quarter. Empowered Funds LLC lifted its holdings in DENTSPLY SIRONA by 8.8% in the 1st quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock worth $244,000 after purchasing an additional 1,320 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB boosted its position in DENTSPLY SIRONA by 13.0% during the fourth quarter. Wilmington Savings Fund Society FSB now owns 13,055 shares of the medical instruments supplier’s stock worth $149,000 after purchasing an additional 1,500 shares during the period. Institutional investors own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

XRAY has been the topic of several analyst reports. Weiss Ratings downgraded DENTSPLY SIRONA from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 6th. Citigroup assumed coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, April 15th. They issued a “sell” rating and a $10.00 price objective for the company. Barclays decreased their price objective on shares of DENTSPLY SIRONA from $12.00 to $9.00 and set an “underweight” rating for the company in a report on Thursday, June 4th. Mizuho lowered their target price on shares of DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. Finally, UBS Group dropped their target price on shares of DENTSPLY SIRONA from $18.00 to $17.00 and set a “buy” rating on the stock in a report on Thursday, May 7th. Three research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $13.42.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $12.93 on Friday. The company has a market cap of $2.59 billion, a price-to-earnings ratio of -4.10, a PEG ratio of 1.51 and a beta of 0.89. The business has a 50 day moving average price of $11.08 and a 200 day moving average price of $11.81. The company has a quick ratio of 0.98, a current ratio of 1.53 and a debt-to-equity ratio of 1.52. DENTSPLY SIRONA Inc. has a twelve month low of $9.40 and a twelve month high of $16.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Tuesday, May 5th. The medical instruments supplier reported $0.27 EPS for the quarter, missing the consensus estimate of $0.28 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 18.83% and a negative net margin of 17.06%.The business had revenue of $880.00 million during the quarter, compared to the consensus estimate of $841.80 million. During the same period in the prior year, the firm earned $0.43 earnings per share. The business’s quarterly revenue was up .1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Research analysts predict that DENTSPLY SIRONA Inc. will post 1.42 earnings per share for the current year.

Insider Transactions at DENTSPLY SIRONA

In related news, Director Michael J. Barber acquired 15,175 shares of the stock in a transaction dated Thursday, June 11th. The shares were acquired at an average price of $9.88 per share, for a total transaction of $149,929.00. Following the completion of the purchase, the director owned 55,943 shares in the company, valued at approximately $552,716.84. The trade was a 37.22% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Brian P. Mckeon bought 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The shares were bought at an average cost of $10.12 per share, for a total transaction of $101,200.00. Following the transaction, the director directly owned 10,000 shares of the company’s stock, valued at $101,200. This trade represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last quarter, insiders have purchased 35,160 shares of company stock worth $351,179. Insiders own 0.46% of the company’s stock.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.